BYSL expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.159800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.428600E-01
Normal-vs-Stage2
2.412600E-01
Normal-vs-Stage3
6.154200E-01
Normal-vs-Stage4
2.530500E-02
Stage1-vs-Stage2
6.865600E-01
Stage1-vs-Stage3
7.733800E-01
Stage1-vs-Stage4
2.624000E-02
Stage2-vs-Stage3
5.006400E-01
Stage2-vs-Stage4
3.417200E-03
Stage3-vs-Stage4
5.359600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.214400E-01
Normal-vs-AfricanAmerican
1.136160E-01
Normal-vs-Asian
1.358430E-01
Caucasian-vs-AfricanAmerican
7.027000E-01
Caucasian-vs-Asian
7.442800E-01
AfricanAmerican-vs-Asian
8.496200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.370800E-01
Normal-vs-Female
1.957420E-01
Male-vs-Female
8.666400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.661170E-01
Normal-vs-Age(41-60Yrs)
2.223400E-01
Normal-vs-Age(61-80Yrs)
2.453200E-01
Normal-vs-Age(81-100Yrs)
9.256300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.878600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.733200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.741000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.288400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.397800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.733800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.770800E-01
Normal-vs-Daily Drinker
4.870200E-01
Normal-vs-Weekly Drinker
7.180300E-02
Normal-vs-Occasional Drinker
2.150400E-01
Normal-vs-Social Drinker
1.988600E-01
Non Drinker-vs-Daily Drinker
3.671400E-01
Non Drinker-vs-Weekly Drinker
1.793420E-01
Non Drinker-vs-Occasional Drinker
2.280200E-01
Non Drinker-vs-Social Drinker
2.023000E-01
Daily Drinker-vs-Weekly Drinker
4.115700E-02
Daily Drinker-vs-Occasional Drinker
7.794200E-02
Daily Drinker-vs-Social Drinker
8.939800E-01
Weekly Drinker-vs-Occasional Drinker
9.935600E-01
Weekly Drinker-vs-Social Drinker
1.810220E-02
Occasional Drinker-vs-Social Drinker
5.788100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.250800E-01
Normal-vs-Grade 2
7.921400E-01
Normal-vs-Grade 3
8.072600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.272600E-01
Grade 1-vs-Grade 3
1.966180E-01
Grade 1-vs-Grade 4
7.250800E-01
Grade 2-vs-Grade 3
7.762800E-01
Grade 2-vs-Grade 4
7.921400E-01
Grade 3-vs-Grade 4
8.072600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.522600E-01
Normal-vs-NonDiabetic
1.811370E-01
Diabetic-vs-NonDiabetic
4.490800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.018800E-01
Normal-vs-NoPancreatitis
2.122600E-01
Pancreatitis-vs-NoPancreatitis
2.687800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.638000E-01
Normal-vs-N1
2.463200E-01
N0-vs-N1
6.914800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.876360E-01
Normal-vs-TP53-NonMutant
2.244400E-01
TP53-Mutant-vs-TP53-NonMutant
1.003810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
